Category: Hepatitis
Global Hepatitis
-
Global Hepatitis A Vaccine Market - 2022-2029
... 3.5% over the forecast period 2022 to 2029. Hepatitis A vaccine is a vaccine that prevents hepatitis A. The disease is a liver disorder caused by the hepatitis A virus leading from mild to severe ... Read More
-
Global Vaccines Market - 2022-2029
... the forecast period (2022-2029). A vaccine is a type of medicine that trains the body’s immune system to fight diseases it has not come into contact with before. Vaccines are developed to prevent disease; when ... Read More
-
Global Infectious Disease In Vitro Diagnostics Market Size study & Forecast, by Product (Instruments, Reagents, Software), by Application (Respiratory Virus, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, HIV, Hepatitis, COVID-19, Others), by Technology (Immunoassay, Molecular Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029
... Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029 Global Infectious Disease In Vitro Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Hepatitis E Diagnostic Tests Market By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, RT-PCR Test), By End User (Hospitals, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... E diagnostic tests market was valued at $61.69 million in 2021, and is projected to reach $93.5 million by 2031, registering a CAGR of 4.2% from 2022 to 2031. Hepatitis E is a type of ... Read More
-
Global Liver Disease Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... organ that plays significant functions like storing vitamins and nutrients, maintaining an adequate balance of chemicals in the body, and removing harmful substances from the blood. Non-alcoholic Fatty Liver Disease, Cancer, hepatitis, autoimmune diseases, and ... Read More
-
Global Hepatitis E Diagnostic Tests Market - 2022-2029
... a CAGR of 4.5 % during the forecast period (2022-2029). The hepatitis E virus causes the enteric liver disease known as hepatitis E. (HEV). It belongs to the group of five known human hepatitis viruses ... Read More
-
Hepatitis C Testing Market By Technique (Immunoassay, PCR, Other techniques), By Test (Antibody test, Genotype tests, Viral load test), By End User (Hospital and diagnostic laboratory, Blood banks, Other end users): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Industry Forecast, 2021-2031 The global hepatitis C testing market was valued at $1,329.0 million in 2021, and is projected to reach $2,248.2 million by 2031, registering a CAGR of 5.3% from 2022 to 2031. Hepatitis ... Read More
-
The 2022 World Market for Vaccines
... some of the deadliest dis eases that pose significant risk to human life. Sales increased from $127.6 billion in 2021 to $202.6 billion in 2022. Compare this to just $25 billion in 2010. Since the ... Read More
-
Global Specialty Generics Market Size study, by Type (Injectables, Oral Drugs, Others), By Application (Oncology, Inflammatory Conditions, Hepatitis C, Multiple Sclerosis, Others) by End-use (, Retail, Hospital, Others) and Regional Forecasts 2022-2028
... Market is valued approximately USD 67.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2022-2028. When a specialty drug's patent expires, it's ... Read More
-
Global Serological Testing Market Size study, by Technology (ELISA, NAT, CLIA/CMIA and Others), Product (Instruments and Consumables & Reagents), Application (Hepatitis, Coronavirus (COVID-19), Human Immunodeficiency Virus (HIV), Rotavirus Infections, And Others), End-User (Diagnostic Laboratories, Hospitals and Other End Users), and Regional Forecasts 2022-2028
... and Other End Users), and Regional Forecasts 2022-2028 Global Serological Testing Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% ... Read More
-
Global Infectious Disease Diagnostics Market Size study, By Product (Reagents, Kits, and Consumables, Instruments, Software & Services), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, Other technologies), By Disease Type (HIV, Hepatitis, HPV, Tuberculosis, Influenza, Other Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Other End-Users), and Regional Forecasts 2022-2028
... Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Other End-Users), and Regional Forecasts 2022-2028Global Infectious Disease Diagnostics Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a ... Read More
-
Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) - Global Forecast to 2027
... global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.Market is driven by factors such as indication of infectious diseases, ... Read More
-
Vaccines Market Analysis and Forecast to 2031: By Technology Type (Recombinant & Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others), Indication (Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Meningococcal Disease, Rotavirus, Varicella, Measles, Mumps, & Rubella, Diphtheria, Pertussis, & Tetanus {DPT}, Polio, Hepatitis, Other Indications), and Region
... Measles, Mumps, & Rubella, Diphtheria, Pertussis, & Tetanus {DPT}, Polio, Hepatitis, Other Indications), and Region Vaccines can be created by using a whole organism, such as a bacterium or virus, or by using parts of ... Read More
-
The 2023-2028 World Outlook for Hepatitis C Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Hepatitis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Hepatitis B Diagnostic Tests
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Global Hepatitis Drugs Market, By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase/NS5A Inhibitor Combinations, Hepatitis C Protease/NS5A Inhibitor Combinations, NS5A Inhibitors, Nucleotide Polymerase Inhibitors, Nucleoside Analogue Antivir
... (Hepatitis B, Hepatitis C, and Others), By Route of Administration (Oral and injection), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, ... Read More
-
The 2023-2028 World Outlook for Hepatitis C Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
Global Hepatitis Diagnostic Testing Market - 2022-2029
... in the forecasted period 2022-2029. Hepatitis is an inflammation of the liver, commonly caused by the hepatitis virus. Heavy alcohol use, some medications, toxins, and certain medical conditions can cause hepatitis. However, hepatitis is often ... Read More
-
The 2023-2028 World Outlook for Hepatitis Test Solution-Diagnosis
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Hepatitis B Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Hepatitis Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Hepatitis C Therapies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Hepatitis C Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
